Should I start Vasopressors
Should I start Vasopressors
ER SURVIVAL GUIDE/Should I start Vasopressors

Should I start Vasopressors

Sub Title
Guidelines for initiating vasopressor therapy in septic shock management.
System
Circulation
Published
Dec 3, 2025
Good posts start with good questions. Have an ER question? Send it here.
KEY
🔍- Deep Dive
📌- Clinical Application
🔸 - Weak Evidence
🔹 - Strong Evidence
📑 - Evidence summaries
✅ - Recommended treatment
⚠️ - Critical Information
I love resuscitating shock — it’s fun, fast, chaotic, and everything I love about EM. But it also comes with a ton of doubts. This post is a breakdown of all the questions that bothered me over the years, distilled into something I hope helps you too.
(Disclaimer: These recommendations DO NOT replace your clinical judgement. Every patient is unique.)
So let’s talk shock, or septic shock ( if you know,you know)

Step 1: Recognize Septic Shock?

According to the Surviving Sepsis Campaign (SSC)
“Septic shock is a subset of sepsis with circulatory and metabolic abnormalities large enough to substantially increase mortality.”
But more importantly for us:
⚠️
Clinical definition = Sepsis + BOTH:
  • Persistent hypotension needing vasopressors to maintain MAP ≥ 65, despite fluids
  • Lactate ≥ 2 mmol/L
Once you recognize shock → resuscitation begins immediately.

Step 2: Fluids

How much?

🔸30 mL/kg crystalloid within the first 3 hours (SSC guideline)

But ER doctors must do better.

notion image
Fluid resuscitation must be individualized.
Assess:
  • Fluid Responsiveness (FR)
  • Fluid Tolerance (FT)

Quick & Oversimplified Guide

FT
FR
Management
Give fluids
Early pressors
Early pressors
Early pressors
⚠️
Low diastolic BP (DAP) → low vascular tone → start NE early
Not a fluid post — that’s coming next 😄
Let’s move on.

Step 3: 1st Vasopresor

Which Pressor First?

🔹Norepinephrine (Noradrenaline) (SSC guidelines)

Why?

  • Potent α-1 + mild β-1 effect
  • Raises MAP with minimal tachycardia

Why NOT the others first?

Dopamine
❌ More arrhythmias
❌ Higher mortality
→ No role in septic shock
Epinephrine
❌ Tachyarrhythmias
❌ Increases lactate
✔ Good in bradycardia / myocardial dysfunction
→ Second/third line
Vasopressin
Not first line because of:
❌ Cost
❌ Availability
✔ Excellent add-on to NE

When to start pressors?

Immediately if MAP < 65
Do NOT wait to finish 30 mL/kg.
Reassess after 10 mL/kg over 10 minutes:
If MAP is still low → start pressors early.

Why early norepinephrine (NE)?

Because septic shock ≠ pure hypovolemia.
  • NE ↑ preload and cardiac output
  • Less time in hypotension → less AKI
  • Improves microcirculation
  • Avoids fluid overload
  • Early BP control = lower mortality
  • CENSER Trial: early NE → better shock control at 6 hours

Peripheral or Central Line?

🔸SSC recommends: Start NE peripherally if needed.
Do NOT delay vasopressors waiting for a central line.
⚠️
Do NOT give vasopressin peripherally.

What Dose of NE?

  • Start: 0.1 mcg/kg/min
  • Titrate to MAP ≥ 65
  • No absolute “maximum” dose

Then why add a second pressor?

To reduce total catecholamine exposure:
  • High NE doses may impair immunity
  • Promote bacterial growth
  • Cause myocardial injury
  • Increase oxidative stress
This principle is called decatecholaminization.

Step 4: 2nd Vasopressor

When to Start the Second Pressor?

👉 When NE = 0.25–0.5 mcg/kg/min and MAP still inadequate.
Instead of escalating NE further.
⚠️
Remember: Reduction of NE dose with MAP ≥ 65 by 6 hours → better outcomes.
Also: Always start steroids when you add a second pressor.

Which Pressor Next?

🔸Vasopressin - (SSC Guideline)

Why Vasopressin?

  • Relative vasopressin deficiency in septic shock
  • Less atrial fibrillation when added to NE
    • (McIntyre et al., JAMA 2018)
  • Lower RRT requirement (VANISH)
  • Improved survival in less severe shock (VASST subgroup)
  • Catecholamine-sparing effect (less NE needed)

Dose

0.03 U/min
⚠️
Vasopressin is never titrated.
Higher doses → cardiac, digital, and splanchnic ischemia.

Should you consider a loading bolus?

Why?
  • Half-life: 15–20 minutes
  • Infusion alone may take ~30 min to show effect
  • 1-unit bolus → rapid MAP rise
  • VALOR Trial: responders had MAP ↑ >18–22 mm + fewer ischemic complications
Why not?
  • Overshoot MAP
  • Ischemia (cardiac, digital. mesentric)
  • VALOR Trial : Not a mortality study, Sample size relatively small
  • No major guideline recommends this yet

When to AVOID Vasopressin

  • Systemic hypoperfusion (cold extremities, mottling)
  • High risk of digital or splanchnic ischemia

When Vasopressin Is GREAT

  • Warm vasoplegic shock (low SVR, high CO)
  • Tachyarrhythmias
  • RV failure
⚠️
A Caveat
🔸If myocardial dysfunction is present:
👉 Use epinephrine, or NE + dobutamine
(No evidence that dobutamine is superior to epinephrine.)

Step 5: 3rd Vasopressor

Still in Shock? Now what?
Before escalating, reconsider your diagnosis.
Remember Hickam’s dictum: “A patient can have as many diseases as he damn well pleases.”
🔸Epinephrine (SSC Guideline)
Especially useful in:
  • Bradycardia
  • Depressed systolic function
  • Refractory shock
notion image

📌

How to Choose Your Pressor (4-Question Method)

Now that you understand each drug, choose based on these:

1️⃣ Peripheral vs Central Access

  • Vasopressin → avoid peripherally
  • NE → safe peripherally short-term

2️⃣ Heart Rate & EF

  • Bradycardia / low EF → NE, Epinephrine
  • Tachycardia / good EF → Vasopressin

3️⃣ RV Failure

  • NE may worsen RV afterload
  • Choose Vasopressin or Epinephrine

4️⃣ When in doubt

👉 Start Norepinephrine.

Want to Read More?

  1. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine 49(11):p e1063-e1143, November 2021. | DOI: 10.1097/CCM.0000000000005337
  1. Kattan, Eduardo, et al. "The emerging concept of fluid tolerance: a position paper." Journal of Critical Care 71 (2022): 154070.
  1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
  1. Permpikul, Chairat, et al. "Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial." American journal of respiratory and critical care medicine 199.9 (2019): 1097-1105.
📚Want to keep learning?

Stay Updated
📸Follow on Instagram
Quick tips, new posts, and simple clinical pearls.

Disclaimer : For educational use only — always follow your clinical judgment and local protocols.